Related Experiment Video
Updated: Dec 9, 2025
Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
Heterozygous retinoblastoma gene mutation compromises in vitro osteogenesis of adipose mesenchymal stem cells - a
Ambily Vincent1, Viswanathan Natarajan2, Vikas Khetan3
1Radheshyam Kanoi Stem Cell Laboratory, Kamalnayan Bajaj Institute for Research in Vision and Ophthalmology, Vision Research Foundation, Chennai, India; School of Chemical and Biotechnology, SASTRA Deemed-to-be University, Thanjavur, India.
Abstract:
Osteosarcoma (OS) is a bone malignancy affecting children and adolescents. Retinoblastoma (RB) patients with germline RB1 mutations are susceptible to osteosarcoma in the second decade of their life. Several studies, particularly in mice, have revealed a role for RB1 in osteogenesis. Since, there is species specific difference attributed in retinoblastoma tumorigenesis between mice and human, we assumed, it is worthwhile exploring the role of RB1 in osteogenesis and thus onset of osteosarcoma. In this study, we analyzed the temporal gene expression of the osteogenic markers, tumor suppressor genes and hormone receptors associated with growth spurt during in vitro osteogenesis of mesenchymal stem cells derived from orbital adipose tissue of germline RB patients and compared it with those with wild type RB1 gene. Mesenchymal stem cells with the heterozygous RB1 mutation showed reduced expression of RB1 and other tumor suppressor genes and showed deregulation of osteogenic markers which could be an initial step for the onset of osteosarcoma.
Insights
Germline RB1 mutations increase osteosarcoma risk in young patients. This study found that RB1 mutations in mesenchymal stem cells disrupt bone formation, potentially initiating osteosarcoma development.
Area of Science:
- Oncology
- Genetics
- Biomedical Research
Background:
- Osteosarcoma (OS) is a primary bone cancer common in children and adolescents.
- Germline RB1 mutations predispose individuals to OS, particularly in their second decade of life.
- The role of RB1 in human osteogenesis and OS pathogenesis requires further investigation due to species-specific differences observed in prior research.
Purpose of the Study:
- To investigate the role of the RB1 gene in osteogenesis and the potential mechanisms leading to osteosarcoma in patients with germline RB1 mutations.
- To compare gene expression patterns during in vitro osteogenesis between mesenchymal stem cells from germline RB patients and those with wild-type RB1.
Main Methods:
- Analysis of temporal gene expression during in vitro osteogenesis of mesenchymal stem cells.
- Mesenchymal stem cells were derived from orbital adipose tissue of germline RB patients and compared with controls having wild-type RB1.
- Key markers analyzed included osteogenic markers, tumor suppressor genes, and hormone receptors associated with growth spurts.
Main Results:
- Mesenchymal stem cells with heterozygous RB1 mutations exhibited reduced expression of RB1 and other tumor suppressor genes.
- Deregulation of osteogenic markers was observed in cells with RB1 mutations.
- These molecular changes suggest a potential early step in osteosarcoma development.
Conclusions:
- Heterozygous RB1 mutations impair normal osteogenesis by downregulating tumor suppressors and disrupting osteogenic marker expression.
- These findings highlight a potential pathway for osteosarcoma development in the context of germline RB1 mutations.
- Further research into RB1's role in bone development is crucial for understanding and potentially preventing osteosarcoma in susceptible individuals.
